Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 148

Results For "patients"

3115 News Found

Ashland Hyderabad laboratory receives ISO certification
News | March 09, 2023

Ashland Hyderabad laboratory receives ISO certification

Ashland’s pharmaceutical business is well known for acetylenics, cellulosics, and film coatings


Evonik and BellaSeno advance commercialization of 3D-printed, bioresorbable implants
News | March 09, 2023

Evonik and BellaSeno advance commercialization of 3D-printed, bioresorbable implants

Resomer used in commercial 3D-printed implants for both soft and hard tissue applications


Alembic Pharmaceuticals gets USFDA final approval for fluorouracil injection
Drug Approval | March 07, 2023

Alembic Pharmaceuticals gets USFDA final approval for fluorouracil injection

Fluorouracil Injection is indicated for the treatment of patients with adenocarcinoma of colon and rectum and breast


Apollo partners with LifeSigns to donate 1000 remote patient monitoring patches to Turkey
News | March 07, 2023

Apollo partners with LifeSigns to donate 1000 remote patient monitoring patches to Turkey

These patches can be used in settings where patients need close vital signs monitoring, including cardiac rhythm.


Sun Pharma completes acquisition of Concert Pharmaceuticals
News | March 07, 2023

Sun Pharma completes acquisition of Concert Pharmaceuticals

The common stock of Concert will no longer be listed for trading on the Nasdaq Global Market


Zydus receives final approval from the USFDA for Vigabatrin for Oral Solution
Drug Approval | March 06, 2023

Zydus receives final approval from the USFDA for Vigabatrin for Oral Solution

Vigabatrin for Oral Solution USP, 500 mg had annual sales of US $233.7 mn in US


Celanese collaborates with Alessa Therapeutics for the advancement of oncology treatments
News | March 04, 2023

Celanese collaborates with Alessa Therapeutics for the advancement of oncology treatments

The collaboration will focus on developing a localized and sustained-release drug delivery system for oncology patients


Zydus receives final approval from the USFDA for Vigabatrin for Oral Solution
Drug Approval | March 04, 2023

Zydus receives final approval from the USFDA for Vigabatrin for Oral Solution

Vigabatrin for Oral Solution USP, 500 mg had annual sales of USD 233.7 mn in the United States


Merck and AstraZeneca updates on US regulatory review of Lynparza for mCRPC
News | March 03, 2023

Merck and AstraZeneca updates on US regulatory review of Lynparza for mCRPC

AstraZeneca and Merck are committed to working with the FDA to bring LYNPARZA in combination with abi/pred to patients diagnosed with mCRPC.


ProBioGen’s growth strategy continues successfully
News | March 03, 2023

ProBioGen’s growth strategy continues successfully

Julian Collins, Jana Windt and Michiel Stork join biopharma company’s leadership team